Mediolanum International Funds »

United Therapeutics Corporation shares owned by Mediolanum International Funds

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Mediolanum International Funds from 13F filings

Historical chart of Mediolanum International Funds investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Mediolanum International Funds consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Mediolanum International Funds

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.9M 5.2k 356.76
2024-03-31 $1.3M 5.2k 243.27

More positions owned by Mediolanum International Funds

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Registerd Shs A Cl A (META)
Alphabet Inc -a- Cap Stk Cl A (GOOGL)
Alphabet Inc -c- Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Visa Inc -a Cl A (V)
Eli Lilly & Co. (LLY)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Accenture Plc Ireland Shs Class A (ACN)
UnitedHealth (UNH)

View all positions for Mediolanum International Funds

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Geode Capital Management
FMR
LSV Asset Management
AQR Capital Management
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Pacer Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation